secwatch.observer — SEC 8-K summary
======================================

Issuer:     Raphael Pharmaceutical Inc. (RAPH)
CIK:        0001415397
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001213900-25-074293
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Raphael Pharma board member resigns; Zvi Laufer Laor appointed as director
--------------------------------------------------------------------------

- Dr. Igal Louria Hayon resigned from Board effective Aug 1, 2025; no disagreement; remains CTO.
- On Aug 7, 2025, Board appointed Zvi Laufer Laor (age 73, lawyer) to fill vacancy.
- Board determined Mr. Laufer qualified and independent under relevant securities laws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415397/000121390025074293/0001213900-25-074293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415397/000121390025074293/ea0252565-8k_raphael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-074293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer